Prazosin hydrochloride
- Product NDC
- 70377-067
- 11-digit product format
- 703770067
- Labeler code
- 70377
- Product ID
- 70377-067_99deacbe-59a1-4e72-8b23-d0f470e2633d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Prazosin hydrochloride
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Biocon Pharma Inc.
- Application
- ANDA213406
- Marketing category
- ANDA
- Marketing start
- 2023-01-09
- Substance
- PRAZOSIN HYDROCHLORIDE
- Active strength
- 2 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Prazosin hydrochloride
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| PRAZOSIN HYDROCHLORIDE | 2 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | X0Z7454B90 |
| Rxcui | 198141, 312593, 312594 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 70377-067-11 | Prazosin hydrochloride | 100 in 1 BOTTLE | CAPSULE | 100 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70377-067 | PRAZOSIN HYDROCHLORIDE CAPSULE [BIOCON PHARMA INC.] | 2 | Current NDC, Legacy NDC, 1 package rows | 20230110_82a84f69-4742-453f-96c8-532fb7df44c6.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70377-067-11 | 70377006711 | 100 CAPSULE in 1 BOTTLE (70377-067-11) | 100 capsule | 2023-01-09 | 0000-00-00 | No | No | Current |